Trendlines Group must show it can build great companies
Stock price has been languishing either because of insufficient understanding of its business or poor public investor appetite for incubators
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
THE Trendlines Group, an Israel-based medtech incubator listed on the Singapore Exchange (SGX), has received a shot in the arm of up to S$2.2 million from Spring Singapore.
The grant that its subsidiary Trendlines Medical Singapore will receive from the enterprise development agency of the Singapore Ministry of Trade and Industry is for the unit to invest in and nurture medical technology (medtech) startups. It comes under the Incubator Development Programme.
But while the financing - the first that the group is receiving from the agency just more than a year after its listing here - attests to the strong local support for its incubation programme and an increasing focus on medtech as a sector, Trendlines' share performance since its November 2015 flotation has not been encouraging for the company.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
